Evidence map›Paper›PMID 26596950›Full record

ArticleAntimicrobial agents and chemotherapy2016

Evaluating 5-Nitrothiazoles as Trypanocidal Agents.

Ivan P O'Shea, Mohammed Shahed, Benjamín Aguilera-Venegas, Shane R Wilkinson

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Synthesis and biological evaluation of thiazole derivatives as LbSOD inhibitors.Journal of enzyme inhibition and medicinal chemistry · 2019
    Article
  8. Article
  9. Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds.European journal of medicinal chemistry · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ivan P O'SheaSchool of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom.
Mohammed ShahedSchool of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom.
Benjamín Aguilera-VenegasLaboratory of Antioxidants, Institute of Nutrition and Food Technology, University of Chile, Santiago, Chile.
Shane R WilkinsonSchool of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom s.r.wilkinson@qmul.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growth-inhibitory properties of a 5-nitrothiazole series were evaluated against Trypanosoma brucei. A subset of related compounds displayed the greatest potency toward the parasite while exhibiting little cytotoxic effect on mammalian cells, with this antiparasitic activity dependent on expression of a type I nitroreductase by the trypanosome. We conclude that the 5-nitrothiazole class of nitroheterocyclic drugs may represent a new lead in the treatment of human African trypanosomiasis.

Indexed as

AnimalsCell LineDrug Evaluation, PreclinicalInhibitory Concentration 50MammalsNitroreductasesStructure-Activity RelationshipThiazolesTrypanocidal AgentsTrypanosoma brucei brucei5-nitrothiazoleNitroreductasesThiazolesTrypanocidal Agents

Identifiers

PMID26596950
PMCPMC4750693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.